Fulgent Genetics Bollinger Bands Expand Downward, Bearish Marubozu Pattern Forms

Fulgent Genetics's 15-minute chart exhibits a pattern of Bollinger Bands expanding downward, accompanied by a bearish Marubozu at 08/20/2025 12:15. This suggests that the market is currently being driven by bearish momentum, with sellers exerting control over the market. Consequently, it is likely that this bearish trend will continue.

Fulgent Genetics (NASDAQ: FLGT) has recently exhibited significant bearish momentum indicators on its 15-minute chart, suggesting a potential downward trend in its stock price. The most notable indicators include a Bollinger Bands pattern with downward expansion and a Bearish Marubozu at 08/20/2025 12:15 [1]. These signals indicate that the market is currently being driven by strong selling pressure, with sellers exerting control over the market.

The Bollinger Bands pattern, characterized by expanding downward, suggests that the stock's volatility is increasing, and the price is likely to continue moving in the downward direction. The Bearish Marubozu pattern, which appeared on August 20, 2025, at 12:15, further supports this bearish sentiment. This pattern is characterized by a single candle with no upper wick, indicating strong selling pressure and a potential downward trend [2].

Despite mixed financial performance reported in the second quarter of 2025, Fulgent Genetics raised its full-year core revenue guidance to $320 million, reflecting strong momentum in its laboratory services and therapeutic development businesses [3]. However, the technical analysis indicates a bearish trend, with the Bollinger Bands and Bearish Marubozu signaling a downward momentum in the stock price [4].

Looking ahead, Fulgent Genetics has forecasted average revenue growth of 9.0% per annum over the next three years, compared to a 6.0% industry growth forecast for the U.S. healthcare sector [1]. However, the technical analysis suggests a bearish trend, with Bollinger Bands and a Bearish Marubozu signaling a downward momentum in the stock price [4].

References:
[1] https://finance.yahoo.com/news/fulgent-genetics-second-quarter-2025-131814335.html
[2] https://www.tipranks.com/news/company-announcements/fulgent-genetics-reports-q2-2025-financial-results
[3] https://www.marketbeat.com/instant-alerts/fulgent-genetics-nasdaqflgt-shares-gap-up-after-earnings-beat-2025-08-01/
[4] https://www.investing.com/news/transcripts/earnings-call-transcript-fulgent-genetics-q2-2025-exceeds-revenue-forecast-stock-surges-93CH-4166152